Dr. Rea Lehner is passionate about transforming healthcare through technology and data. She has extensive experience leading digital health projects from proof-of-concept to large-scale implementation across academic and pharmaceutical settings, contributing to clinical trials in neurological, neurodevelopmental, and autoimmune diseases. Previously, she co-led a research program at the Singapore-ETH Centre, developing innovative digital health technologies in close collaboration with clinical partners and governmental agencies to meet future healthcare needs. Dr. Lehner currently serves as a Digital Biomarker Science and Technology Lead at Roche, where she leads cross-functional teams in developing and implementing remote patient monitoring strategies for drug development.
